This story has been corrected to clarify that Compugen received orders from Prot@gen and not Protogene.

NEW YORK, Dec 1 – Compugen said Friday it had received orders from Pfizer and Prot@gen of Germany for its Z3 proteomics software and expects to announce several more commercial users in the near future.

“Several pharmas are acquiring the product and we expect that by the end of the year we will have six or seven clients,” Lior Ma’ayan, vice president of commercial operations at Compugen, told GenomeWeb.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.